Navigation Links
RXi Pharmaceuticals Announces Positive Data in Second Phase 1 Multi-Dose Study
Date:7/12/2013

WESTBOROUGH, Mass., July 12, 2013 /PRNewswire/ -- RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA® compound that targets Connective Tissue Growth Factor (CTGF), and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.

In this study, subjects received small skin incisions in their abdomen and were treated with 3 intradermal doses of RXI‑109 over a 2-week period.  This dose escalating study consisted of 3 cohorts of 3 healthy volunteers each.  Subjects received RXI‑109 on one side of the abdomen, and placebo on the other side. Subjects were monitored for safety and local and systemic side effects over a total study period of 84 days. Multiple dermal injections were well tolerated at all doses, and treatment with RXI‑109 resulted in dose-dependent silencing of CTGF mRNA in the treated areas.

Dr. Geert Cauwenbergh, President and CEO of RXi Pharmaceuticals said that, "We are very pleased with the outcome of this second Phase 1 study.  These results show that multiple intradermal injections of RXI‑109 are well tolerated with minimal and mild side effects. He added that, "The work done in the last year has confirmed that our proprietary self-delivering RNAi technology (sd-rxRNA) reduces CTGF mRNA in humans in line with its mechanism of action. Indeed, results from this second study demonstrate that mRNA for CTGF in the incisions is reduced in a dose-dependent manner by RXI‑109 as compared to placebo. Our first Phase 1 study had already shown that a single dose of the drug l
'/>"/>

SOURCE RXi Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. UCBs Kremers Urban Pharmaceuticals Inc. receives FDA approval for extended release methylphenidate hydrochloride
2. Tris Pharmas Generic Pharmaceuticals Business Launches Dextroamphetamine Sulfate Oral Solution
3. Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macovens Discontinuance of Certain Products
4. Kinex Pharmaceuticals Will Take the Lead in the Orascovery Program Development in China
5. Actinium Pharmaceuticals Clinical Results Featured at a United Nations Forum
6. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
7. Vanda Pharmaceuticals, Inc. Sued by Investor
8. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9. Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
10. Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
11. Oramed Pharmaceuticals to Present Findings on Oral Insulin to the American Diabetes Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 2, 2014  MJ Freeway®, the industry-leading cannabis business ... detailing upcoming legalization efforts in Oregon ... Nevada .  The success of the measures being ... on the national level. On October 7th, ... the Marijuana Policy Project, an organization dedicated to making ...
(Date:10/2/2014)... , Oct. 2, 2014  Isis Pharmaceuticals, Inc. ... webcast:What: , Webcast and conference call to provide ... clinical studies of ISIS-SMN Rx in infants ... will be presented on the morning (CEST) of ... Muscle Society in Berlin, GermanyWhen:Friday, October 10 at ...
(Date:10/1/2014)... Calif. , Oct. 1, 2014  Abaxis, Inc. ... manufacturing point-of-care instruments and consumables for the medical, research, ... to the veterinary and research markets in ... entered into a definitive distribution agreement with Patterson Veterinary ... and promote the full line of Abaxis veterinary products ...
Breaking Medicine Technology:MJ Freeway to Host Educational Webinars Regarding Crucial Marijuana Legalization Efforts in Alaska, Nevada and Oregon 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 3Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 4
(Date:10/2/2014)... Oct. 1, 2014 (HealthDay News) -- Genes may interact with ... study suggests. The genetic risk occurs in about 13 ... The finding could help these people reduce their heart disease ... diet and stress management, the Duke University researchers said. ... and found a strong link between variations in the EBF1 ...
(Date:10/2/2014)... Dennis Thompson HealthDay ... -- Hospitals that pull out all the stops to ... saving lives, but the cost of such heroism is ... are about 5 percent better at saving elderly patients ... that operate with less intensity, said senior author Dr. ...
(Date:10/1/2014)... of scientists has shown that more than 80 per ... drugs. , The study found that medicines called ,JAK ... genetic mutation that is present in more than 80 ... currently used, or are in clinical trials, for diseases ... , Bowel cancer is the second-most common cancer in ...
(Date:10/1/2014)... Despite a policy focus on expanding access to ... population continues to have significant dental disease. In ... the American Dental Association , researchers from Tufts ... of Dental Medicine report on the first large-scale ... provided by caregivers to adults with developmental disabilities. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Bedros Keuilian ... Body Boot Camp fitness boot camps, he’s also considered ... training , with sold out business summits, a line ... marketing consultant to a recent Spike TV reality show ... that now is the time for personal trainers and ...
Breaking Medicine News(10 mins):Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3
... Limited (Nasdaq: FFHL ) (the "Company"), a manufacturer ... today,announced the convening of its Annual Meeting of the ... New York City., The Meeting will take place ... Avenue, New York, New York, beginning at 9 a.m. ...
... Only one-third to one-half of those getting treatment reach ... (HealthDay News) -- Almost 75 percent of American adults ... have high blood pressure. , That,s the finding of ... data from 4,646 adults who took part in a ...
... AUSTIN, Texas, Dec. 12 According to ... taxpayers are annually defrauded of,about $60 billion in ... A new system developed by S3 Matching Technologies ... on reducing Medicare,and Medicaid fraud with algorithmic data ...
... Services,International Inc (Pink Sheets: MSITF) predicts that revenues will ... to June 2008) of its fiscal,year. The predicted revenues ... account the internet sales that the Company expects in ... the company has developed several new,products that will be ...
... of regulation on small businesses will help lawmakers ... a new RAND Corporation report. , The ... an overview of the ways that regulation and ... entrepreneurial spirit. It also examines how specific ...
... CHARLOTTE, N.C., Dec. 11 Recent developments regarding,North ... the North,Carolina Coalition on Donation to hire Corder ... and tissue donors., These developments include a ... Commission, enabling the Coalition to update their online,registry ...
Cached Medicine News:Health News:Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City 2Health News:Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City 3Health News:High Blood Pressure Key Factor for Cardiovascular Disease 2Health News:Technology can Dramatically Reduce Billions of Dollars in Medicaid, Medicare Fraud 2Health News:Medical Services International Predicts Revenues for the Second Half of the Year 2Health News:Rand study examines the effect of policy on entrepreneurship and small businesses 2Health News:North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: